# China Industrial Asset Management

> China Industrial Asset Management is a VC fund in Shanghai backing Biotechnology and Medical. See 13 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 13
- Last investment: Jul 2025
- Lead investor: 31%
- Last updated: Aug 2026
- Website: http://www.ciamc.com.cn

China Industrial Asset Management is an asset management company under China Industrial Bank.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 31% |
| Medical | 3 | 23% |
| Pharmaceutical | 3 | 23% |
| Biopharma | 2 | 15% |
| Manufacturing | 2 | 15% |

22 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 5 | 38% |
| Series A | 3 | 23% |
| Series B | 2 | 15% |
| Seed | 1 | 8% |
| Venture - Series Unknown | 1 | 8% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 10 | 77% |
| Australia | 1 | 8% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Tuoxin Tiancheng | Tuoxin Tiancheng is a clinical-stage biopharmaceutical company focused on the development of immunotherapy for solid tumors. | $40M | Series B | Jul 15, 2025 |  |
| eCactus | eCactus is a battery storage system company for homes. |  | Series A | Dec 15, 2023 |  |
| Fullcryo | Fullcryo provides solutions for helium extraction from natural gas, hydrogen liquefaction, and liquefied hydrogen storage. | $111.7M | Series C | Aug 03, 2023 |  |
| Affinity | Affinity Biomedical Technology is a clinical biopharmaceutical company focusing on the development of global innovative anticancer drugs. |  | Series B | Jul 06, 2023 |  |
| ProBio Inc. | GenScript ProBio is a one-stop biopharmaceutical R&D and production platform. It provides end-to-end services for cell and gene therapy drugs, vaccine and biopharmaceutical discovery, antibody protein drugs. | $220M | Series C | Jan 18, 2023 |  |
| Stemirna | Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science. The company currently has more than a dozen of independently-developed mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious disease, protein defects diseases, andgenetic diseases, providing cure and solutions for cancer and infectious diseases, better serving patients. | $187.4M | Series C | Jun 03, 2021 |  |
| Vzoom Creditech | Vzoom Creditech is a big data credit information and big data risk control service provider company. | $7.4M | Venture - Series Unknown | Apr 02, 2019 |  |
| Shanghai Cell Therapy Group | Shanghai Cell Therapy Group is a provider of cellular diagnosis center combining cellular research and treatment services.The company is involved in cellular cold storage, cellular pharmaceuticals, antibody research, enabling patients to do genetic testing and providing research data to cancer facilities. | $131.1M | Series C | Dec 17, 2018 |  |
| Shanghai Cell Therapy Group | Shanghai Cell Therapy Group is a provider of cellular diagnosis center combining cellular research and treatment services.The company is involved in cellular cold storage, cellular pharmaceuticals, antibody research, enabling patients to do genetic testing and providing research data to cancer facilities. | $39M | Series C | Nov 26, 2018 |  |
| Yitu Technology | They are pioneer of artificial intelligence research and innovation.YITU Technology integrates advanced AI technology business applications to build a safer, faster and healthier world. YITU maintains an outstanding R&D team to drive industrial development with advanced technologies. Rather than simply using technologies from large companiesor laboratories for monetary gains, they are engaged in fundamental research of artificial intelligence aimed to find comprehensive solutions for machine vision, listening and understanding. They strive for breakthroughs in computer vision, natural language understanding, knowledge reasoning, intelligent hardware and robotics. Today YITU has an extensive presence in sectors such as security, finance, transportation and healthcare.They are curious about human wisdoms, and they expand the potential of AI. Side by side, They look forward to creating an intelligent future with you. | $100M | Series C | Jul 17, 2018 |  |

10 of 13 investments shown.

## Co-investors
- [Legend Capital](https://shizune.co/investors/profile/legend-capital) — VC Fund, 3 deals together
- [CITIC Securities](https://shizune.co/investors/profile/citic-securities) — VC Fund, 2 deals together
- [GSR United Capital](https://shizune.co/investors/profile/gsr-united-capital) — VC Fund, 2 deals together
- [Guangzhou Yuexiu Industrial Investment Fund](https://shizune.co/investors/profile/guangzhou-yuexiu-industrial-investment-fund) — VC Fund, 2 deals together
- [CD Capital](https://shizune.co/investors/profile/morning-road-capital) — VC Fund, 2 deals together
- [Advantech Capital](https://shizune.co/investors/profile/advantech-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Breakthrough Energy Ventures](https://shizune.co/investors/profile/breakthrough-energy-ventures) — VC Fund

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Artesian VC](https://shizune.co/investors/profile/artesian-capital-management) — VC Fund
- [Blackbird Ventures](https://shizune.co/investors/profile/blackbird-ventures-australia) — VC Fund

## Featured in investor lists
- [Energy VC Funds in Australia](https://shizune.co/investors/energy-vc-funds-australia)
- [Real Estate VC Funds in Australia](https://shizune.co/investors/real-estate-vc-funds-australia)

## FAQ

### What does China Industrial Asset Management invest in?

China Industrial Asset Management invests primarily in Biotechnology, Medical and Pharmaceutical startups, most often at Series C and Series A stage. Most of the 13 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did China Industrial Asset Management last invest?

The most recent investment recorded for China Industrial Asset Management closed in Jul 2025. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co